<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats
2
Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed C57BL/6N mice
3
Oral administration of heparin or heparosan increases the Lactobacillus population in gut microbiota of rats
4
Oral Administration of IL-12 Suppresses Anaphylactic Reactions in a Murine Model of Peanut Hypersensitivity
5
Oral administration of IL-1β enhanced the proliferation of lymphocytes and the O2− production of neutrophil in newborn calf
6
Oral administration of IL-1β enhanced the proliferation of lymphocytes and the O2− production of neutrophil in newborn calf
7
Oral administration of insulin included in fine W/O/W emulsions to rats
8
Oral administration of leaf extracts to rumen liquid donor lambs modifies in vitro gas production of other tree leaves
9
Oral administration of marijuana produces alterations in serotonin 5-hydroxytryptamine receptor 3A gene (HTR3A) and electrolyte imbalances in brain of male Wistar rats
10
Oral Administration of Morphine Delays Neural Plate Development in Rat Embryos
11
Oral administration of Nitraria retusa ethanolic extract enhances hepatic lipid metabolism in db/db mice model ‘BKS.Cg-Dock7m+/+ Leprdb/J’ through the modulation of lipogenesis–lipolysis balance
12
Oral administration of NO synthase inhibitor failed to promote arteriosclerotic lesions in the aorta and the coronary arteries of rabbits fed cholesterol Original Research Article
13
ORAL ADMINISTRATION OF NUTMEG ON MEMORY BOOSTING AND REGAINING IN WISTAR ALBINO RATS
14
Oral administration of omega-7 palmitoleic acid induces satiety and the release of appetite-related hormones in male rats
15
ORAL ADMINISTRATION OF PEPTIDERGIC GROWTH HORMONE (GH) SECRETAGOGUE KP102 STIMULATES GH RELEASE IN GOATS
16
oral administration of probiotic enterococcus durans to ameliorate experimental autoimmune encephalomyelitis in mice
17
Oral administration of rac-α-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial
18
Oral administration of recombinant epinecidin-1 protected grouper (Epinephelus coioides) and zebrafish (Danio rerio) from Vibrio vulnificus infection and enhanced immune-related gene expressions
19
Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis
20
Oral administration of tepoxalin in the horse: A PK/PD study
21
Oral Administration of Testosterone in Fish Diet Affect Sex Differentiation and Testis Development in Tilapia.
22
Oral Administration of the Aqueous Extract of Rosmarinus Officinalis in Rats Before Renal Reperfusion Injury
23
Oral administration of the nitric oxide biosynthesis inhibitor, N-nitro-l-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance, in rats
24
Oral administration of titanium dioxide nanoparticle through ovarian tissue alterations impairs mice embryonic development
25
Oral administration of titanium dioxide nanoparticle through ovarian tissue alterations impairs mice embryonic development
26
Oral administration of triethylenetetramine (TETA) reduces some inflammatory markers in streptozotocin-induced diabetes mellitus in rat
27
Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults
28
Oral administration of type II collagen suppresses non-specifically induced chronic arthritis in rats
29
Oral administration of type-II collagen peptide 250–270 suppresses specific cellular and humoral immune response in collagen-induced arthritis
30
Oral Administration of Vitamin C, Cimetidine and Famotidine on Micronuclei Induced by Low Dose Radiation in Mouse Bone Marrow Cells
31
Oral administration of yeast, Saccharomyces cerevisiae, enhances the cellular innate immune response of gilthead seabream (Sparus aurata L.)
32
Oral administration of yeast, Saccharomyces cerevisiae, enhances the cellular innate immune response of gilthead seabream (Sparus aurata L.)
33
Oral Administration of Zataria multiflora Extract Decreases IL-17 Expression in Perennial Allergic Rhinitis
34
Oral administration of zinc sulphate in treatment of acute cutaneous leishmaniasis
35
Oral administration versus intra-peritoneal injection of Pb affects its concentration in selected rat tissues
36
Oral agents for the treatment of type 2 diabetes mellitus: Pharmacology, toxicity, and treatment
37
Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis
38
Oral Allergy Syndrome Associated with Jicama
39
Oral allopurinol desensitization
40
Oral ambroxol supplement in pregnant women induces fetal lung maturation
41
Oral Ambu-bag insufflation to remove unilateral nasal foreign bodies
42
Oral Amelanotic Melanoma of the Maxilla
43
Oral Amino Acid Administration Decreases Oxidative Stress and Improves Brachial Reactivity in Elderly Individuals
44
Oral amino acid administration in patients with diabetes mellitus: supplementation or metabolic therapy?
45
Oral amiodarone and atrial fibrillation
46
Oral amiodarone and atrial fibrillation
47
Oral amiodarone and atrial fibrillation
48
Oral amiodarone and atrial fibrillation
49
Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial
50
Oral amiodarone reduces incidence of postoperative atrial fibrillation
51
Oral amoxicillin for childhood pneumonia
52
Oral amoxicillin for childhood pneumonia
53
Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study
54
Oral Amoxicillin-Clavulanic Acid Treatment in Urinary Tract Infections Caused by Extended-Spectrum Beta-Lactamase–Producing Organisms
55
Oral analgesia compared with intravenous patient-controlled analgesia for pain after cesarean delivery: A randomized controlled trial
56
Oral and anal immunisation with alloantigen induces active cell-mediated cytotoxic responses in carp
57
Oral and Colonic Microbiomes and Colon Cancer
58
Oral and dental complications caused by methamphetamine use: A Review
59
Oral and dental health in hospitalized psychiatric patients: a cross-sectional and comparative study in Kerman, Iran
60
Oral and dental health of non-institutionalized elderly people in Spain
61
Oral and Dental Health Status in Patients with Primary Antibody Deficiencies
62
Oral and Dental Laser Treatments for Children: Applications, Advantages and Considerations
63
Oral and Dental Status, Oral Health-Related Quality of Life and Associated Factors among Institutionalized Elderly in Southeast Iran-A Cross Sectional Study
64
Oral and injectable synthetic progestagens effectively manipulate the estrous cycle in the Przewalskiʹs horse (Equus ferus przewalskii)
65
Oral and intestinal digestion of oligosaccharides as potential sweeteners: A systematic evaluation
66
Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections
67
Oral and Intravenous ltraconazole for Systemic Fungal Infections in Neutropenic Haematological Patients: Meeting Report
68
Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: Pharmacokinetic considerations and clinical implications
69
Oral and Jaw Lesions in Adults: A 19-Year Retrospective Study In Northern Iran
70
Oral and Laryngeal Diadochokinetic Rate in Multiple Sclerosis: Relationship to Disease Progression
71
Oral and maxillofacial complications of COVID-19 infection: A review
72
Oral and Maxillofacial Injuries in Civilian Recruits During Mandatory Combat Training at Military Garrisons: A Nationwide Survey
73
Oral and Maxillofacial Lesions in an Elderly Population in Shiraz, Iran
74
Oral and maxillofacial manifestations of hereditary sensory neuropathy
75
Oral and Maxillofacial Manifestations of Neurological Diseases in Southern Provinces of Iran
76
Oral and maxillofacial medicine curriculum and practice for undergraduate dental students: A comparative study of Iranian universities and other countries
77
Oral and Maxillofacial Pathology in Three Dimensions
78
Oral and maxillofacial tumours in children and adolescents: Clinicopathologic audit of 75 cases in an academic medical centre, Sokoto, Northwest Nigeria
79
Oral and maxillofacial tumours in children: a review
80
Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses
81
Oral and parenteral vaccination of mice with protein-ergotamine conjugates and evaluation of protection against fescue toxicosis
82
Oral and parenteral vaccination of mice with protein-ergotamine conjugates and evaluation of protection against fescue toxicosis
83
Oral and Pharyngeal Cancer in Women
84
Oral and pharyngeal cancers in Yemen: a retrospective study
85
Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Aβ(25–35)-induced abnormal tau protein immunoreactivity in rat brain
86
Oral and Systemic Conditions in Elderly Population Groups in Talash, North of Iran
87
Oral and Systemic Conditions in Elderly Population Groups in Talash, North of Iran
88
Oral and Systemic Conditions in Elderly Population Groups in Talash, North of Iran
89
Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals
90
Oral and vulvar changes in pregnancy
91
Oral antibiotic administration and early hospital discharge is a safe and effective alternative for treatment of low-risk neutropenic fever: Abstracted from: Innes HE, Smith DB, O’Reilly SM et al. Oral antibiotics with early hospital discharge compared wi
92
Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy
93
Oral Antibiotic Use Following Stented Hypospadias Repair: Does It Play a Role in the Prevention of Urinary Tract Infections?
94
Oral Antibiotic use without consulting a Physician: A survey of ED patients
95
Oral antibiotics better in low-risk cancer patients
96
Oral antibiotics for the treatment of severe pneumonia in children
97
Oral anticoagulant therapy—An algorithm to facilitate control
98
Oral anticoagulants and fetal loss
99
Oral anticoagulants and fetal loss
100
Oral anticoagulants and fetal loss
101
Oral anticoagulants and fetal loss
102
Oral anticoagulants and fracture risk: Clinical perspectives
103
Oral anticoagulants in patients with coronary artery disease
104
Oral anticoagulants: Pharmacogenetics: Relationship between genetic and non-genetic factors
105
Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention
106
Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort
107
Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison
108
Oral anticoagulation strategies after a first idiopathic venous thromboembolic event
109
Oral Antidiabetic Utilization and Various Factors as an Indicator for HbA1c Control Among Patients with Type 2 Diabetes
110
Oral antifungal agents for onychomycosis
111
Oral antifungal agents for onychomycosis
112
Oral antifungals as prophylaxis in haematological malignancy
113
Oral antihypertensive trial design and analysis under the pediatric exclusivity provision
114
Oral Aphthous: Pathophysiology, Clinical Aspects and Medical Treatment
115
Oral arginine supplementation in acute liver injury
116
Oral arsenic trioxide poisoning and secondary hazard from gastric content
117
Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial Original Research Article
118
Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat
119
Oral Bacteria and Colorectal Pathology
120
Oral bacterial deactivation using a low-temperature atmospheric argon plasma brush
121
Oral bacterial deactivation using a low-temperature atmospheric argon plasma brush
122
Oral Bacterial Ecology. The Molecular Basis: H.K. Kuramitsu and R.P. Ellen. Horizon Scientific Press, England, 2000; 314 pages, hard back; £74.79; US $149.99; ISBN: 1-898486-22-0; http://www.horizonpress.com: E-mail: griffin@horizonpress.com
123
Oral bacterial lipopolysaccharide acts in mice to promote sensitisation to ovalbumin and to augment anaphylaxis via platelets
124
Oral behaviour of food hydrocolloids and emulsions. Part 1. Lubrication and deposition considerations
125
Oral behaviour of food hydrocolloids and emulsions. Part 2. Taste and aroma release
126
Oral bioaccessibility and human risk assessment of organochlorine pesticides (OCPs) via fish consumption, using an in vitro gastrointestinal model
127
Oral bioaccessibility of potentially toxic elements (PTEs) in urban dusts of Abakaliki,Ebonyi State, Nigeria
128
Oral bioaccessibility testing and read-across hazard assessment of nickel compounds
129
Oral bioavailability and pharmacokinetic study of cetrizine HCl in Iranian healthy volunteers
130
Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS
131
Oral Bioavailability of Quercetin in Horses
132
Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles
133
Oral bioavailability, tissue distribution and depletion of flumequine in the food producing animal, chicken for fattening
134
Oral biodrug delivery using cell-penetrating peptide
135
Oral Biopsy: A Dental Gawk
136
Oral blistering diseases
137
Oral blockade of the platelet glycoprotein IIb/IIIa receptor: Fact or fancy?,
138
Oral bone loss induced by mineral deficiency in a rat model: Effect of a synthetic bone mineral (SBM) preparation
139
Oral Breathing Increases Pth and Vocal Effort by Superficial Drying of Vocal Fold Mucosa
140
Oral cadmium exposure throughout puberty does not inhibit secretion of prolactin, GH and ACTH through dopamine metabolism changes in male rat
141
Oral Cancer Awareness among Dentists in Kuwait
142
Oral Cancer Awareness and Knowledge among Marginalised Group in Sungai Petani, Kedah, Malaysia
143
Oral Cancer Detection
144
Oral cancer early symptom variations: pain as the first symptom in oral cancer patients
145
Oral cancer exams among cigarette smokers in Maryland
146
Oral Cancer in Developing Countries: The Time to Act Is Upon Us
147
Oral Cancer Knowledge among Patients Referred to Mashhad Dental School, Iran
148
Oral Cancer Prevention: The Case for Carotenoids and Anti-Oxidant Nutrients
149
Oral cancer screening: 5 minutes to save a life
150
Oral cancer, fever of unknown origin, and listeriosis
151
Oral cancer, smoking and alcohol: the patients’ perspective
152
Oral cancer: a retrospective study of 100 Danish cases
153
Oral cancer: leukoplakia and squamous cell carcinoma
154
Oral Cancer: Leukoplakia, Premalignancy, and Squamous Cell Carcinoma
155
Oral cancer: Nanoparticles as a new horizon in the diagnosis and phototherapy-based therapies
156
Oral Cancer: Prevention and Early Detection, Dentists’ Opinions and Practices (Mashhad-Iran)
157
Oral cancer—pertinent papers 2002–2003 A personal view
158
Oral Cancer—pertinent papers 2003–2004: A personal view
159
Oral Candida albicans biotypes in chinese patients with and without oral candidosis
160
Oral Candida colonization and anti-fungal susceptibility pattern in patients with hematological malignancy
161
Oral Candidal Infections and Treatment
162
Oral Candidiasis among Cancer Patients Attending a Tertiary Care Hospital in Chennai, South India: An Evaluation of Clinicomycological Association and Antifungal Susceptibility Pattern
163
Oral candidiasis and nutritional deficiencies in elderly hospitalised patients
164
Oral Candidiasis in Hematological Malignancy Patients: Identification and Antifungal Susceptibility Patterns of Isolates
165
Oral candidosis:
166
Oral cannabinoids for spasticity in multiple sclerosis: will attitude continue to limit use?
167
Oral Capecitabine Achieves Response in MetastaticEccrine Carcinoma
168
Oral Capecitabine in Combination with Gemcitabine in Management of Advanced Pancreatic Carcinoma
169
Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1)
170
Oral carcinogenesis induced by 4-nitroquinoline 1-oxide in lecithin:retinol acyltransferase gene knockout mice
171
Oral care and pneumonia
172
Oral Care as A Subject of Patient Safety in Neurosurgical Intensive Care Units
173
Oral Care during Mechanical Ventilation Significantly Reduces the Incidence of Ventilator-Associated Pneumonia
174
Oral care experiences with 181 nasopharyngeal carcinoma patients receiving radiotherapy in a Taiwanese hospital
175
Oral care help to maintain nutritional status in frail older people
176
Oral Care in Patients Receiving Mechanical Ventilator
177
Oral Care in Trauma Patients Admitted to the ICU: Viewpoints of ICU Nurses
178
Oral Care Program for Successful Long-Term Full Mouth Habilitation of Patients with Hypohidrotic Ectodermal Dysplasia
179
Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients
180
ORAL CAVITY CANCERS AND CLASSIFICATION
181
ORAL CAVITY CANCERS IN NORTH WEST PAKISTAN: A HOSPITAL BASED STUDY
182
Oral cavity cancers treated with superselective intra-arterial chemoradiotherapy with radiation doses less than 60 Gy: implications for dose reduction from a propensity score-matched analysis
183
Oral Cavity Lesions in Patients after Chemotherapy
184
Oral Cephalosporin Cefodox for treatment of out patient pneumonia in children
185
Oral chlodronate in pagetʹs disease
186
Oral Chloral Hydrate Compare with Rectal Thiopental in Pediatric Procedural Sedation and Analgesia; a Randomized Clinical Trial
187
Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis
188
Oral choristoma in one and a half year-old ouda ewe: a case report
189
Oral chromoblastomycosis: a case report
190
Oral cimetidine (Tagamet) for recalcitrant, diffue conjunctival papillomatoi
191
Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study
192
Oral Ciprofloxacin Compared with Intravenous Ceftazidim on Low Risk Febrile Neutropenia in Acute Lymphocytic Leukemia
193
Oral Ciprofloxacin Prophylaxis in Patients Undergoing High Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation
194
Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment
195
Oral Clefts: A review of the cases and our experience at a single institution
196
Oral Clonidine Premedication Decreases Intraoperative Bleeding in Patients Undergoing Endoscopic Sinus Surgery
197
Oral Clonidine Premedication Reduces Nausea and Vomiting in Children after Appendectomy
198
Oral cobalamin remains medicineʹs best kept secret
199
Oral cobalamin therapy
200
Oral cobalamin therapy for the treatment of patients with food-cobalamin malabsorption
201
Oral colon delivery of insulin with the aid of functional adjuvants
202
Oral colonisation by aerobic and facultatively anaerobic Gram-negative rods and yeast in Tibetans living in Lhasa
203
Oral colonization and cariogenicity of Streptococcus gordonii in specific pathogen-free TAN:SPFOM(OM)BR rats consuming starch or sucrose diets
204
Oral colonization by more than one clonal type of mutans streptococcus in children with nursing-bottle dental caries
205
Oral colonization of Acinetobacter baumannii in intensive care units: Risk factors, incidence, molecular epidemiology, association with the occur of pneumonia and sepsis, and infection control measures
206
Oral Colonization of Staphylococcus Species in a Peritoneal Dialysis Population: A Possible Reservoir for PD-Related Infections?
207
Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkins lymphoma: Evaluation of the role of G-CSF; Quality-of-life analysis and long-term follow-up
208
Oral combination therapy in primary care
209
ORAL COMMUNICATION ABILITY IN ENGLISH: AN ESSENTIAL SKILL FOR ENGINEERING GRADUATES
210
Oral Communication Apprehension (OCA) among Undergraduate Accounting and Journalism Students in Bangladesh
211
Oral Communication Apprehension among English Senior Majors at Al-Quds Open University in Palestine
212
Oral Communication Apprehension and Affective Factors: Self-esteem and Introversion/Extroversion
213
Oral Communication Development in Severe to Profound Hearing Impaired Children After Receiving Aural Habilitation
214
Oral Communication Skills of Engineering Students of Pakistan in Perspective of Industrial Internships
215
Oral communication strategies and multiple intelligences: Exploring the relationship
216
Oral Communication Strategies Used by Iranian EFL Learners and their Relationship with the Learners’ Self-efficacy Beliefs and Anxiety Level
217
Oral Communication Strategies Used by Iranian EFL Learners: Focus on Language Proficiency and Cultural Background
218
Oral Complications of Congestive Heart Failure Drugs in Patients Referred to Heart Clinics in Birjand (Iran) in 2016
219
Oral Conditions Might Cause Severe Outcomes in Patients With Viral Hepatitis Infection
220
Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women
221
Oral Consumption of D-Glucose Increases Blood Glucose Levels but does not Alter the False Memory Effect using the Deese-Roediger-McDermott task in a Non-Diabetic Sample
222
Oral consumption of Hydro-alcoholic extract of Dactylorhiza maculate (Salep) Prevents Appetite and Body Weight in Male Rats
223
Oral contraception and the recognition of endometritis, ,
224
Oral contraception and the risk of hepatocellular carcinoma
225
Oral contraceptive alert in UK sparks off controversy
226
Oral contraceptive and smoking mortality
227
Oral contraceptive and smoking mortality
228
Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons, , ,
229
Oral contraceptive effects on food choice during the follicular and luteal phases of the menstrual cycle. A laboratory based study
230
Oral contraceptive induced thrombi of the right heart of a heterozygous protein C-deficient woman—a case report
231
Oral contraceptive intake in women with focal nodular hyperplasia of the liver
232
Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis
233
Oral contraceptive pill use and changes in obsessive–compulsive symptoms
234
Oral contraceptive pills and inherited thrombophilia in a young woman with deep venous thrombosis
235
ORAL CONTRACEPTIVE PILLS CONSUMPTION an‎d CEREBRAL VENOUS THROMBOSIS
236
Oral Contraceptive Steroids Promote Papillary Thyroid Cancer Metastasis by Targeting Angiogenesis and Epithelial-Mesenchymal Transition
237
Oral Contraceptive Therapy Increases Oxidative Stress in Pre-Menopausal Women
238
Oral contraceptive use and glucose metabolism in a national sample of women in the United States
239
Oral Contraceptive Use and the Occurrence of Gallstone Disease - A Case-Control Study
240
Oral contraceptive use and venous thromboembolism: Translating epidemiologic data late clinical practice
241
Oral contraceptive use in perimenopause
242
Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis
243
Oral contraceptive-related transverse sinus thrombosis as an initial manifestation of antiphospholipid syndrome in the absence of systemic lupus erythematosus
244
Oral contraceptives and bone mineral density: A population-based study,
245
Oral contraceptives and cervical cancer
246
Oral contraceptives and cervical cancer
247
Oral contraceptives and cervical cancer
248
Oral contraceptives and cervical cancer
249
Oral contraceptives and fatal pulmonary embolism Original Research Article
250
Oral contraceptives and mortality from venous thromboembolism
251
Oral contraceptives and mortality from venous thromboembolism
252
Oral contraceptives and mortality from venous thromboembolism
253
Oral contraceptives and mortality from venous thromboembolism
254
Oral contraceptives and mortality from venous thromboembolism
255
Oral contraceptives and myocardial infarction
256
Oral contraceptives and premenstrual symptoms: Comparison of a 21/7 and extended regimen
257
Oral contraceptives and risk of familial breast cancer
258
Oral contraceptives and risk of hip fractures
259
Oral contraceptives and stroke risk: the debate continues
260
Oral contraceptives and the risk of focal nodular hyperplasia of the liver: A case-control study
261
Oral contraceptives and venous thromboembolism
262
Oral contraceptives and venous thromboembolism
263
Oral contraceptives and venous thromboembolism
264
Oral contraceptives and venous thromboembolism
265
Oral contraceptives and venous thromboembolism
266
Oral contraceptives and venous thromboembolism
267
Oral Contraceptives Can Cause Falsely Low Vitamin B12 Levels
268
Oral contraceptives do not raise risk of heart disease
269
Oral contraceptives that contain ethinyl estradiol (0.035 mg) and cyproterone acetate (2 mg) inhibit leukocyte transmigration through endothelial cell monolayers
270
Oral contraceptives, parity, and cervical cancer
271
Oral corrective feedback in the foreign language classroom: how it affects interaction in analytic foreign language teaching
272
Oral Corrective Feedback Preferences in Iranian L2 Learners with Different Proficiency Levels
273
Oral corticosteroids and bone pain after pamidronate in adults with cystic fibrosis
274
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial Original Research Article
275
Oral creatine supplementation in humans does not elevate urinary excretion of the carcinogen N-nitrososarcosine
276
Oral cysticercosis
277
Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: randomized, double-blind, placebo-controlled study
278
Oral d,l-sotalol in atrial fibrillation and/or flutter
279
Oral decitabine reactivates fetal hemoglobin in baboons (Papio anubis)
280
Oral delivery of DNA construct using chitosan nanoparticles to protect the shrimp from white spot syndrome virus (WSSV)
281
Oral delivery of G protein-coupled receptor modulators: An explanation for the observed class difference
282
Oral delivery of heparin: SNAC and related formulations
283
Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells
284
Oral Delivery of Insulin from Trimethyl Chitosan/Tragacanth: In Vitro, MTT, and In Vivo Bioactivity Tests
285
Oral delivery of live yeast Debaryomyces hansenii modulates the main innate immune parameters and the expression of immune-relevant genes in the gilthead seabream (Sparus aurata L.)
286
Oral delivery of proteins by biodegradable nanoparticles
287
Oral delivery of salmon calcitonin
288
Oral delivery of salmon calcitonin
289
Oral developmental toxicity study of methylsulfonylmethane in rats
290
Oral dexamethasone for the treatment of pain in children with acute pharyngitis: A randomized, double-blind, placebo-controlled trial
291
Oral Dexmedetomidine Versus Midazolam as Anesthetic Premedication in Children Undergoing Congenital Heart Surgery
292
ORAL DEXMEDETOMIDINE VERSUS ORAL MIDAZOLAM AS PREMEDICATION IN CHILDREN
293
Oral d-fenfluramine test in treatment-refractory depression: Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group
294
Oral Diagnostic Testing for Detecting Human Immunodeficiency Virus-1 Antibodies: A Technology Whose Time Has Come
295
Oral Diagnostics for the Geriatric Populations: Current Status and Future Prospects
296
Oral dietary supplements before and after surgery
297
Oral dietary supplements before and after surgery
298
Oral dietary supplements in pre- and postoperative surgical patients: a prospective and randomized clinical trial
299
Oral Diphenhydramine-Midazolam Versus Oral Diphenhydramine for Pediatric Sedation in the Emergency Department
300
Oral Direct Renin Inhibition: Premise, Promise, and Potential Limitations of a New Antihypertensive Drug
301
Oral Disease Burden in Patients Undergoing Prosthetic Heart Valve Implantation
302
Oral disorders: unapproved treatments or indications
303
Oral docosahexaenoic acid given to pregnant mice increases the amount of surfactant in lung and amniotic fluid in preterm fetuses
304
Oral doxycycline for neuroborreliosis
305
Oral Doxycycline Reduces the Total Number of Intraocular Bevacizumab Injections Needed to Control Neovascular Age-related Macular Degeneration
306
Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial
307
Oral drug absorption enhancement by chitosan and its derivatives
308
Oral drug delivery systems using chemical conjugates or physical complexes
309
Oral drug delivery utilizing intestinal OATP transporters
310
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
311
Oral drug self-administration: an overview of laboratory animal studies
312
Oral ecosystem alterations in celiac children: A follow-up study
313
Oral Embryonal Rhabdomyosarcom in an Adult Addict Man: a case report and review of literature
314
Oral English Communication Difficulties and Coping Strategies of Diploma of Hotel Management Students at UiTM
315
Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: Comparative pharmacokinetics and drug–drug interactions
316
Oral Erosive Lichen Planus Regression After Thymoma Resection
317
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: A phase II study with a 5-year follow-up
318
Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men Original Research Article
319
Oral etoposide and palliative treatment for small-cell lung cancer
320
Oral exposure of Kunming mice to diisononyl phthalate induces hepatic and renal tissue injury through the accumulation of ROS. Protective effect of melatonin
321
Oral exposure to the organophosphorus insecticide, Monocrotophos induces intestinal dysfunction in rats
322
Oral extended release of dexamethasone: Montmorillonite–PLGA nanocomposites as a delivery vehicle
323
Oral fecal parasites and personal hygiene of food handlers in Abeokuta, Nigeria
324
ORAL FEEDBACK IN CLASSROOM SLA A Meta-Analysis
325
Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4+ CD45RBhigh T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation
326
Oral fennel (Foeniculum vulgare) drop effect on primary dysmenorrhea: Effectiveness of herbal drug
327
Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers
328
Oral Fibrolipoma: A Report of Two Cases
329
Oral Fibrolipoma-A Rare Histological Entity: Report of 3 Cases and Review of Literature
330
Oral fibrosis among teenagers chewing tobacco, areca nut, and Pan masala
331
Oral findings and health status among hospitalized patients with physical disabilities, aged 60 or above
332
Oral Findings and Salivary Parameters in Children with Celiac Disease: A Preliminary Study
333
Oral findings in children with celiac disease
334
Oral Findings in Newborn Children in and around Mangalore, Karnataka State, India
335
Oral Findings, Salivary Bicarbonate, and Phosphate Levels in Patients with Gastroesophageal Reflux Disease
336
Oral flecainide is not sensitive enough to rule out Brugada-Syndrome
337
Oral Fluid Antibody Detection in the Diagnosis of Gastric Helicobacter pylori Infection
338
Oral fluid collection by post—a pilot study of two approaches
339
Oral fluid proteolytic effects on histatin 5 structure and function
340
Oral Fluid Therapy for Treatment of Neonatal Diarrhoea in Calves
341
Oral fluid therapy in paediatric burns (5–10%): an appraisal
342
Oral Focal Mucinosis: A Case Report and Literature Review
343
Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli
344
Oral fumarate for relapsing-remitting multiple sclerosis
345
Oral Functional Assessment Training in Speech Therapy Students using Virtual Reality (VR)
346
Oral functional outcome after intraoral reconstruction with nasolabial flaps
347
Oral fungal infections
348
Oral Gabapentin for the Treatment of Potoperative Pain after Photorefractive Keratectomy Original Reearch Article
349
Oral Gabapentin Treatment for ymptomatic Heimann-Bielchowky Phenomenon
350
Oral Gabapentin Versus Rectal Diclofenac for Postoperative Analgesia
351
Oral ganciclovir fails to prevent CMV in HIV trial
352
Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilot study
353
Oral glucocorticoids diminish the efficacy of allergen-specific immunotherapy in experimental feline asthma
354
Oral glucosamine increases expression of transforming growth factor β1 (TGFβ1) and connective tissue growth factor (CTGF) mRNA in rat cartilage and kidney: Implications for human efficacy and toxicity
355
Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E
356
Oral glucose retention, saliva viscosity and flow rate in 5-year-old children
357
Oral glucose supplementation improved semen quality and constituents of seminal and blood plasma of NZW buck rabbits in the subtropics
358
ORAL GLUCOSE TOLERANCE TEST (OGTT) IN NORMAL CONTROL AND GLUCOSE INDUCED HYPERGLYCEMIC RATS WITH COCCINIA CORDIFOLIA L. AND CATHARANTHUS ROSEUS L.
359
Oral glucose tolerance test and the preparatory diet,
360
Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts
361
Oral glutamine does not prevent bacterial translocation in rats subjected to intestinal obstruction and Escherichia coli challenge but reduces systemic bacteria spread
362
Oral glutamine prevents DMBA-induced mammary carcinogenesis via upregulation of glutathione production
363
Oral glutamine: does it make sense?
364
Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease
365
Oral glycoprotein IIb/IIIa inhibition—great idea, but it didn’t work
366
Oral Graft-Versus-Host Disease
367
Oral Graft-Versus-Host Disease
368
Oral Granular Cell Tumor: A Case Report with Emphasis on Pseudoepitheliomatous Hyperplasia in Oral Lesions
369
Oral Grapeseed Oil and Sesame Oil in Experimental Acetic Acid-Induced Ulcerative Colitis in Rat
370
Oral Hairy Leukoplakia: Clinical Indicator of an Immunosuppressive Condition and Challenges in Patient Management
371
Oral Health among 35- to 44-Year-Old Iranians
372
Oral health and bone mineral density in postmenopausal women
373
Oral Health and Coronary Artery Disease, A Review Article
374
Oral Health and Coronary Artery Disease, A Review Article
375
Oral Health and Dental Care During Pregnancy
376
Oral health and general health at the early stage of ageing: A review of contemporary studies
377
Oral health and linear growth in primary school children: a five-year longitudinal study
378
Oral Health and Oral Health Related Quality of Life among Elderly People in Iran
379
Oral Health and Pediatricians: Results of a National Survey
380
Oral Health and Quality of Life Among Elderly in Thailand
381
Oral health and quality of life in New Zealand: A social perspective
382
Oral Health and Related Quality of Life in Older People: A Sys-tematic Review and Meta-Analysis
383
ORAL HEALTH AND SALIVARY PROFILES OF GERIATRIC OUTPATIENTS IN CIPTO MANGUNKUSUMO GENERAL HOSPITAL
384
Oral health and school performance in elementary students: A cross-sectional study in a group of Iranian students, Tehran, Iran
385
Oral Health and Treatment Needs among 18-Year-Old Iranians
386
Oral Health Awareness and Practices of Special Needs Caregivers in Qatif, Saudi Arabia
387
Oral Health Awareness and Status among Universiti Kebangsaan Malaysia First Year Dental Students
388
Oral Health Behavior and Its Relationship with Quality of Life among 12 Year-old Children of Rafsanjan in 2017-18
389
Oral health behavior differences between dental students in graduate and doctoral programs
390
Oral Health Behaviors in a Sample of Portuguese Adolescents: An Educational Issue
391
Oral health behaviour and self-esteem in Swedish children
392
Oral Health Behaviours and Preventive Dental Care Experiences Among Patients with Special Health Care Needs at Special Care Dentistry Clinic, University of Malaya
393
Oral health behaviours in relation to caries and gingivitis in primary-school children in Tehran, 2008
394
Oral Health Burden in Children with Systemic Diseases
395
Oral Health Care Behavior in a Group of Turkish Children
396
Oral Health Care Education Regarding the Gingival Health, Knowledge, Attitude, and Behavior of the Pregnant Women
397
Oral Health Change in Iran: Part V; It Is the Time to Focus on MIH by an Electronic Approach - Letter to the Editor
398
Oral Health Characteristics and Dental Rehabilitation of Children with Global Developmental Delay
399
Oral Health Determinants among Opium Users in Kerman, Iran
400
Oral Health Disparities in Older Adults: Oral Bacteria, Inflammation, and Aspiration Pneumonia
401
Oral Health Disparities in the United States
402
Oral Health Disparity in Older Adults: Dental Decay and Tooth Loss
403
Oral health during pregnancy: A study from women with pregnancy
404
Oral health education program among pre-school children: an application of health-promoting schools approach
405
Oral Health Impact Profile and Associated Variables in Southern Brazilian Drug Users
406
Oral Health in Children: A Pediatric Health Priority
407
Oral health in long-term care: The implications of organizational culture
408
Oral health in pregnancy (Guidelines to gynaecologists, general physicians oral health care providers)
409
Oral Health In The Population Of Iasos (Byzantine Period)
410
Oral Health Indices in Patients With Type 2 Diabetes Receiving Insulin Treatment Compared With Metformin: A Cross-sectional Study
411
Oral Health Inequalities among and Within Neo‑Marxian Social Classes in South Korea: A Nationwide Cross‑sectional Study
412
Oral Health Information Being Delivered to Yazd Population in 2011
413
Oral Health Is a Challenging Problem for Patients with Schizophrenia: A Narrative Review
414
Oral Health Issues for Adolescent Athletes
415
Oral Health Knowledge and Attitudes of Community Health Workers in East Azerbaijan, Iran
416
Oral health knowledge and sources of information among male secondary school children in Riyadh
417
Oral health knowledge in parents of Saudi cerebral palsy children
418
Oral health Knowledge of Diabetic Patients before and after the Education Package
419
Oral health knowledge of health care workers in special children’s center
420
Oral health knowledge, attitude and behaviour among Saudi school students in Jeddah city
421
Oral health knowledge, attitude and practices among health professionals in King Fahad Medical City, Riyadh
422
Oral Health Knowledge, Attitude, and Practice among Nursing Students in the NorthEastern Part of Rajasthan, India
423
Oral health knowledge, attitude, and status and oral health index among midwifery students of Tehran University of Medical Sciences, Iran
424
Oral Health Knowledge, Attitude, Behavior, and Self-efficacy Among Healthcare Professionals: A Cross-sectional Study
425
Oral health knowledge, attitudes and practices of people with diabetes in South of Tehran, Iran
426
Oral health knowledge, behaviour and practices among school children in Qatar
427
Oral Health Literacy Among Carers of Special Needs Children in Kuala Terengganu, Malaysia
428
Oral Health Literacy and Behaviour of Health Sciences University Students
429
Oral Health Literacy and its Determinants in Young Couples
430
Oral Health Literacy and Oral Health Behavior among Adolescents in Babol 2019
431
Oral Health Literacy and Oral Health Behavior of Senior Medical and Pharmacy Students
432
Oral health literacy and oral health behaviors of disadvantaged women residing in the slum area of Zahedan, Iran: A cross-sectional study
433
Oral Health Literacy in Iran: Insights from a Cross-Sectional Study on the Adult Population
434
Oral health literacy status among adult population of Iran: A systematic review
435
Oral Health Literacy: The New Imperative to Better Oral Health
436
Oral Health of Children with Autism: The Influence of Parental Attitudes and Willingness in Providing Care
437
Oral Health of Down Syndrome Adults in Bosnia and Herzegovina
438
Oral Health of Drug Abusers: A Review of Health Effects and Care
439
Oral health of elderly occupants in residential homes
440
Oral Health of Fasting Muslims
441
Oral health of Iranian children in 2004: a national pathfinder survey of dental caries and treatment needs
442
Oral health of psychiatric patients: A cross-sectional comparision study
443
Oral Health Opinions and Practices of Pediatricians: Updated Results From a National Survey
444
Oral Health Policy Amicable for the South Asian Association for Regional Cooperation Nations
445
Oral Health Policy Development Since the Surgeon Generalʹs Report on Oral Health
446
Oral health problems and mortality
447
Oral Health Professionals Within State-Sponsored Medical Response Teams: The IMERT Perspective
448
Oral Health Profile in Iranian Armed Force: Focusing on Prevention Strategies
449
Oral health related quality of life among adults reffered to dental clinic of Babol faculty of dentistry in 2009-2011
450
Oral health related quality of life and decay-missing-filled teeth in children with attention deficit hyperactivity disorder
451
ORAL HEALTH RELATED QUALITY OF LIFE AND PERIODONTAL STATUS OF A SELECTED MALAYSIAN ADULT POPULATION: A PILOT STUDY
452
Oral Health Related Quality of Life in Diabetic Patients
453
Oral health related quality of life in Indonesian middle-aged and elderly women
454
Oral health related quality of life in patients with diabetes mellitus type 2 in the year 2012
455
Oral health related quality of life in patients with head and neck tumors undergoing chemo and radiotherapy
456
Oral Health Related Quality of Life of Patients Using Conventional Dentures versus Implant-Supported Overdentures
457
Oral Health Status and its Determinants among a Group of Iranian Employees
458
Oral health status and oral health behavior of substance abusers in Kerman city, Iran, in year 2016
459
Oral health status and oral hygiene behaviour of orphan children: A survey in support centers in Kerman City, Iran, in 2019
460
Oral Health Status and Related Factors among Adult Patients Referred to Public Health Centers (Kerman-Iran)
461
oral health status and related factors in children with visual impairment aged 7-11 years: a cross-sectional study
462
Oral Health Status and Salivary Properties Among Children Before and After Tonsillectomy
463
ORAL HEALTH STATUS AND TREATMENT NEEDS OF A SCREENED UNIVERSITY POPULATION IN PORT HARCOURT, RIVERS STATE
464
Oral Health Status and Treatment Needs of Visual Impairment in Phitsanuloke, Thailand
465
Oral health status in patients with epilepsy
466
Oral health status in preschool asthmatic children in Iran.
467
Oral Health Status in the Iranian Elderly: The Role of Nutrition Status and Health Literacy
468
Oral Health Status in the Pars Cohort Study
469
Oral Health Status in Three Long Term Care Units of Schizophrenic Patients in Chaharmahal-Bakhtiari Province, Iran
470
Oral Health Status of 12 and 15YearOld Students in Qatar: Findings From the National Oral Health Survey
471
Oral health status of 12-year-old male schoolchildren in Medina, Saudi Arabia
472
Oral health status of a sample of disabled population in Iran
473
Oral Health Status of Children with Autistic Spectrum Disorder Compared with Non-authentic Peers
474
Oral Health Status of Children with Disability Living in Albania
475
Oral health status of disabled children
476
Oral Health Status of Low Birth Weight and Preterm Children
477
Oral health status of male adolescent smokeless tobacco users in Saudi Arabia
478
Oral Health Status of Patients Visiting Islamic International Dental Hospital
479
Oral health status of school children in Mbarara, Uganda
480
Oral health status of southern Chinese following head and neck irradiation therapy for nasopharyngeal carcinoma
481
Oral Health Status of the Professional Soccer Players in Thailand
482
Oral health status, dental needs, habits and behavioral attitude towards dental treatment of a groupof autistic children in Riyadh, Saudi Arabia
483
Oral health status, knowledge, attitude and practice of patients with heart disease
484
Oral health status, salivary flow rate and salivary quality in children, adolescents and young adults with ADHD
485
Oral health status, salivary pH status, and Streptococcus mutans counts in dental plaques and saliva of children with acute lymphoblastic leukemia
486
Oral health status, self‑perceived dental needs, and barriers to utilization of dental services among people with psychiatric disorders reporting to a tertiary care center in Haryana
487
Oral health, sociodemographic factors, dietary and oral hygiene practices in Jordanian children
488
Oral Health-Related Factors based on Health Belief Model in 10th to 12th-Grade Students in Kashan
489
Oral Health-Related Quality of Life among Parents and Teachers of Disabled Schoolchildren in Kuwait
490
Oral Health-Related Quality of Life Changes Following Third Molar Surgery in a Jordanian Population: Effect of Demographic and Clinical Factors on the Immediate Postoperative Period
491
Oral Health‑related Quality of Life in Older People in Kashan/Iran 2015
492
Oral Health-Related Quality of Life in Temporomandibular Disorder Patients Treated with Stabilization Splint
493
Oral health-related quality of life: a broader perspective
494
Oral Health-Related Quality of Life: A Cross-Sectional Survey among Adult Patients in Mashhad, Iran
495
Oral Hemorrhage in a 3-year-old Boy Caused by Self-Mutilating Behavior
496
Oral herbal supplement containing magnesium sulfate improve metabolic control and insulin resistance in non-diabetic overweight patients: A randomized double blind clinical trial
497
Oral herpetic infections (HSV 1–8)
498
Oral Histoplasmosis: Report of Two Cases
499
Oral Hobnail Hemangioma: A Case Report
500
Oral hygiene assessment by school teachers and peer leaders using simplified method
501
Oral hygiene awareness among female Saudi school children
502
Oral hygiene awareness among female Saudi school children
503
Oral Hygiene Behaviors and Oral Health Literacy Among Informal Thai Workers in Rural Areas
504
Oral Hygiene Behaviour Change in Dentistry Students During Dental Education
505
Oral hygiene evaluation for effective oral care in preventing pneumonia in dentate elderly
506
Oral Hygiene Evaluation Of The Patients Before Orthodontic Treatment
507
ORAL HYGIENE HABITS AND ORAL HEALTH STATUS OF FEMALE ADOLESCENTS UNDER STATE PROTECTION: A PILOT STUDY
508
Oral Hygiene Practices and Bottle Feeding Pattern Among Children with Early Childhood Caries: A Preliminary Study
509
Oral hygiene practices and dietary habits among children with Down’s Syndrome in Riyadh, Saudi Arabia
510
Oral hygiene reduces respiratory infections in elderly bed-bound nursing home patients
511
Oral Hygiene Status in a General Population of Iran, 2011: A Key Lifestyle Marker in Relation to Common Risk Factors of Non-Communicable Diseases
512
Oral hygiene status of Kuwaiti schoolchildren
513
Oral hypoglycemic agents in coronary artery bypass grafting
514
Oral hypoglycemics sold as valium on the streets: A case report
515
Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis
516
Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens
517
Oral Ibuprofen for Closure of Hemodynamically Significant Patent Dultus Arteriosus in Premature Neonates: a Pilot Study
518
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term
519
Oral imipramine and intravenous xylazine for pharmacologically-induced ex copula ejaculation in stallions
520
Oral immunisation of pigs with fimbrial antigens of enterotoxigenic E. coli: an interesting model to study mucosal immune mechanisms
521
Oral immunisation of pigs with fimbrial antigens of enterotoxigenic E. coli: an interesting model to study mucosal immune mechanisms
522
Oral immunization induces local and distant mucosal immunity in swine
523
Oral immunization induces local and distant mucosal immunity in swine
524
Oral immunization of olive flounder (Paralichthys olivaceus) with recombinant live viral hemorrhagic septicemia virus (VHSV) induces protection against VHSV infection
525
Oral immunization of rainbow trout to infectious pancreatic necrosis virus (Ipnv) induces different immune gene expression profiles in head kidney and pyloric ceca
526
Oral immunization of the African clawed frog (Xenopus laevis) upregulates the mucosal immunoglobulin IgX
527
Oral immunization of the African clawed frog (Xenopus laevis) upregulates the mucosal immunoglobulin IgX
528
Oral Immunization with Enterocoated Microbeads Induces Antigen-Specific Cytolytic T-Cell Responses
529
Oral immunotherapy for food allergy: Clinical and preclinical studies
530
Oral Immunotherapy in Children: Ige-Dependent Food Allergy to Milk or Wheat
531
Oral Immunotherapy to Wheat in Allergic Asthmatic Female: A Case Report
532
Oral Immunotherapy to Wheat in Allergic Asthmatic Female: A Case Report
533
Oral impact on daily performance in Iranian adults
534
Oral Implications of Polypharmacy in the Elderly
535
Oral infection with human papillomavirus 16 common in children
536
Oral Infections and Glycemic Control in Pregnant Type 2 Diabetics
537
Oral infections and systemic diseases
538
Oral infiltrating lipomas
539
Oral ingestion of lidocaine for suicide: A case report
540
Oral inhibitors of platelet membrane receptor glycoprotein IIb/IIIa in clinical cardiology: Issues and opportunities, ,
541
Oral inoculation of Enterococcus faecalis, DNA quantification and histopathological evaluation of gingival, heart and kidney tissue samples in rats
542
Oral inoculation with Gymnorhynchus gigas induces anti-parasite anapyhylactic antibody production in both mice and rats and adverse reactions in challenge mice
543
Oral insulin administration and residual (β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial
544
Oral insulin delivery by self-assembled chitosan nanoparticles: In vitro and in vivo studies in diabetic animal model
545
Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination
546
Oral Intake of Semi-refined Carrageenan by Rats Affects Apoptosis of Lymphocytes
547
Oral intravascular papillary endothelial hyperplasia: a case report
548
Oral involvement in autoimmune blistering diseases
549
Oral iron chelators – development and application
550
Oral Iron Therapy with Polysaccharide-Iron Complex May be Useful in Increasing the Ferritin Level for a Short Time in Patients with Dilated Cardiomyopathy
551
Oral Isobutyramide Therapy in Patients with Thalassemia Intermedia: Results of a Phase II Open Study
552
Oral keratinocytes cultured on dermal matrices form a mucosa-like tissue
553
Oral Ketamine or Nasal Midazolam for Sedation in Pediatric Upper Gastrointestinal Endoscopy
554
Oral ketoprofen is effective in the treatment of non-infectious lameness in sows
555
Oral l -arginine prevents murine coxsackievirus B3 myocarditis
556
Oral laquinimod for treatment of relapsing-remitting multiple sclerosis
557
Oral L-arginine (and other active ingredients) for ischemic heart disease?
558
Oral L-Arginine Administration Improves Anthropometric and Biochemical Indices Associated With Cardiovascular Diseases in Obese Patients: A Randomized, Single Blind Placebo Controlled Clinical Trial
559
Oral l-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men
560
Oral l-arginine supplementation impacts several reproductive parameters during the postpartum period in mares
561
Oral Lesion Description: A Mini Review
562
Oral Lesions among Women Living with or at Risk for HIV Infection
563
Oral Lesions Associated with Human Immunodeficiency Virus Disease
564
Oral Lesions in Kidney Transplant Patients
565
Oral lesions in patients with severe COVID-19 in the National Institute of Respiratory Diseases in Mexico: Case series
566
Oral lesions in Saudi renal transplant patients
567
Oral lesions of 500 habitual psychoactive substance users in Chennai, India
568
Oral leukoplakia: Diagnosis and treatment
569
Oral leukoplakia: Transmission electron microscopic correlation with clinical types and light microscopy
570
Oral Levetiracetam as Add-On Therapy in Refractory Neonatal Seizures
571
Oral Levofloxacin Versus Intravenous Cefotaxime in the Treatment of Patients with Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial
572
Oral levosimendan improves cardiac function and hemodynamics in patients with severe congestive heart failure
573
Oral lichen planus
574
Oral Lichen Planus and Celiac Disease: is there any Relationship?
575
Oral Lichen Planus and Lichenoid Mucositis
576
Oral lichen planus and the burning mouth syndrome. Is there a role for patch testing?
577
Oral lichen planus in a child in association with psychological stress: A case report
578
Oral Lichen Planus in a Pediatric Patient: A Novel Therapeutic Approach
579
Oral Lichen Planus or Oral Lichenoid Reaction? A Literature Review
580
Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study
581
Oral lichen planus: a review
582
Oral Lichen Planus: Clinical Features, Etiology, Treatment and Management; A Review of Literature
583
Oral Lichen Planus: Diagnosis and Management
584
Oral lichen planus: Focus on etiopathogenesis
585
Oral Lichen Planus: Treatment of a Refractory Case (Case Report)
586
Oral Lichenoid Reaction: An Uncommon Side Effect of Rituximab
587
Oral lipid-based formulations
588
Oral Lipoma in Elderly Saudi Patient: A Case Report
589
ORAL LIPOMA: CASE REPORT
590
Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation
591
Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study
592
Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC)
593
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A stress echocardiographic study
594
Oral Lymphoma Prevalence in Iranian Population: A Multicenter Retrospective Study
595
Oral Lymphoma Prevalence in Iranian Population: A Multicenter Retrospective Study
596
Oral Magnesium Supplementation Decreases C-reactive Protein Levels in Subjects with Prediabetes and Hypomagnesemia: A Clinical Randomized Double-blind Placebo-controlled Trial
597
Oral Magnesium Supplementation Improves the Metabolic Profile of Metabolically Obese, Normal-weight Individuals: A Randomized Double-blind Placebo-controlled Trial
598
Oral magnesium supplementation in insulin-requiring patients with type 2 diabetes mellitus
599
Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease
600
Oral Magnesium; Migraine Prophylaxis
601
Oral malignant melanoma: A case report of an unusual clinical and histologic presentation
602
Oral malodor reduction by a palatal mucoadhesive tablet containing herbal formulation
603
Oral Malodor-A Menace To Periodontist
604
Oral malodorous compounds are periodontally pathogenic and carcinogenic
605
Oral management of patients following oncology treatment: literature review
606
Oral manganese intake estimated with dietary records and with direct chemical analysis
607
Oral Manifestation and Caries Experience in Pre-Dialysis Chronic Kidney Disease Patient
608
Oral Manifestation and Dental Management of CATCH 22 Syndrome
609
Oral Manifestation and Presence of Candida albicans in Multiple Sclerosis Disease with Different Treatment Modalities
610
Oral Manifestation Associated with Biochemical and Hematological Changes in Iraqi End-Stage Renal Failure Patients
611
Oral Manifestations and Complications of Diabetes Mellitus
612
Oral Manifestations and Dental Management Considerations of Lipoid Proteinosis: A Case Report and Review of Literature
613
Oral Manifestations and Its Associated Factors in Iranian Systemic Lupus Erythematosus (SLE) Patients
614
ORAL MANIFESTATIONS AND PROSTHETIC REHABILITATION IN HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY (HSAN)TYPE IV: A CASE REPORT
615
Oral manifestations and related factors of HIV positive patients in south-east of Iran
616
Oral manifestations and related factors of HIV positive patients in south-east of Iran
617
Oral manifestations associated with human immunodeficiency virus infection in 200 Indian patients.
618
Oral Manifestations in COVID-19: a Missed Diagnostic Clue or a Mispresented Secondary Complication
619
Oral manifestations in inflammatory bowel disease: A cross‑sectional study in Isfahan
620
Oral manifestations in liver transplant recipients
621
Oral Manifestations in Obesity and Bariatric Surgery: Narrative Review
622
Oral Manifestations in Patients with Psoriasis: A Cross-Sectional Study
623
Oral manifestations in transplant patients
624
Oral manifestations of allograft recipients before and after renal transplantation
625
Oral Manifestations of Aplastic Anemia: A Case Report
626
Oral manifestations of drug therapy
627
Oral Manifestations of Ehlers-Danlos Syndrome and Presentation of a Case
628
Oral manifestations of HIV disease
629
Oral manifestations of HIV infection
630
Oral Manifestations of Human Immunodeficiency Virus-Infected Patients
631
Oral Manifestations of Internal Malignancy and Paraneoplastic Syndromes
632
Oral manifestations of lamellar ichthyosis: A rare case report and review
633
Oral Manifestations of Patients Taking Anti-Hypertensive Medications
634
Oral manifestations of patients with lupus erythematosus
635
Oral manifestations of sexually transmitted diseases
636
Oral manifestations of Systemic Sclerosis and Correlation with anti-Topoisomerase I Antibodies (SCL-70)
637
Oral Manifestations Related To CD4 Lymphocyte Count in HIV-Positive Patients
638
Oral Manifestations With Tissue Alterations of Nas or Pan Consumption: A Case Study in Bandar Abbas (Iran) in 2018
639
Oral mature teratoma containing epididymal tissue in a female neonate
640
Oral melanoma with pulmonary metastasis in a Nigerian local dog
641
ORAL MELANOSIS: A CASE SERIES
642
Oral Melatonin for Colistin-induced Nephrotoxicity Reduction in Intensive Care Unit: A Randomized Placebo Controlled Clinical Trial
643
Oral melatonin in neurologically disabled children
644
Oral melatonin in neurologically disabled children
645
Oral melatonin in neurologically disabled children
646
Oral Melatonin Versus Midazolam as Premedication for Intravenous Sedation in Pediatric Dental Patients
647
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
648
Oral metastases: report of 24 cases
649
Oral Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report
650
Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion,
651
Oral methotrexate for treatment of ectopic pregnancy
652
Oral Methylated N-Aryl Chitosan Derivatives for Inducing Immune Responses to Ovalbumin
653
ORAL MICROBES AND ITS ENVIRONMENT: A REVIEW ARTICLE
654
Oral microbial colonization in children with sickle cell anaemia under long-term prophylaxis with penicillin
655
Oral Microbiome in Head and Neck Cancers: An Insight, Are We Looking at a Step Beyond in Unraveling the Challenge?
656
Oral Microflora in Patients on Hemodialysis and Kidney Transplant Recipients
657
Oral microflora of stray domestic cats (Felis catus) found in the premises of two human hospitals in Sokoto, Nigeria
658
Oral Midazolam and Emergence Delirium
659
Oral Midazolam for Voiding Dysfunction in Children Undergoing Voiding Cystourethrography: A Controlled Randomized Clinical Trial
660
Oral Midazolam Vs Promethazine as Pre Sedation Medication in Pediatric Dentistry
661
Oral Midazolam-Ketamine versus Midazolam alone for Procedural Sedation of Children Undergoing Computed Tomography; a Randomized Clinical Tri-al
662
Oral misoprostol for postpartum haemorrhage
663
Oral misoprostol for premature rupture of membranes at term
664
Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial
665
Oral misoprostol or vaginal dinoprostone for labor induction: A randomized controlled trial
666
Oral misoprostol versus oxytocin in the management of third stage of labour
667
Oral morphine consumption reduces lens development in rat embryos
668
Oral morphology and dietary choices of goats on rangeland
669
Oral motor patterns during feeding in severely physically disabled children
670
Oral mucoceles: A clinical, histopathological and immunohistochemical study
671
Oral mucosa and Streptococcus mutans count in the saliva. Does graphene oxide nanoparticle mouthwash have a good effect?
672
Oral mucosa grafts for urethral reconstruction
673
Oral mucosa lesions and risk habits: a cross-sectional study in North Serbia student population
674
ORAL MUCOSA MYIASIS CAUSED BY OESTRUS OVIS
675
Oral mucosal embryology and histology
676
Oral Mucosal Lesions and Adverse Habits Among Hospitalized Tuberculosis Patients of Udaipur, Rajasthan, India
677
Oral mucosal lesions and developmental anomalies in dental patients of a teaching hospital in Northern Taiwan
678
Oral mucosal lesions and risk factors in elderly dental patients
679
Oral mucosal lesions in complete denture wearers
680
Oral mucosal lesions: a retrospective review of one institution’s 13-year experience
681
Oral mucosal manifestations in primary and secondary Sjögren syndrome and dry mouth syndrome
682
Oral mucosal pigmentation secondary to treatment with mepacrine, with sparing of the denture bearing area
683
Oral mucosal wetness in hypo- and normosalivators
684
Oral mucositis
685
Oral mucositis in patients with leukaemia following high-dose chemotherapy and autologous haematopoietic stem cells transplantation
686
Oral Mucositis Prevention and Management by Therapeutic Laser in Head and Neck Cancers
687
Oral Mucous Membrane Pemphigoid With Positive Nikolsky’s Sign: A Case Report
688
Oral multiple sclerosis treatment gains support
689
Oral Myiasis Affecting Gingiva in a Child Patient: An Uncommon Case Report
690
Oral myiasis by screwworm Cochliomyia hominivorax
691
Oral Myiasis: A Rare Case Report and Literature Review
692
Oral Narratives by Hearing-Impaired Students in Ordinary Schools- A SFG Study
693
Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor
694
Oral Nitrate Reductase Activity Is Not Associated with Development of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Pilot Study
695
Oral nodular fasciitis: case report
696
Oral Oncoprevention by Phytochemicals - A Systematic Review Disclosing the Therapeutic Dilemma
697
Oral Opportunistic Bacteria in Multiple Sclerosis with Different Treatment Modalities
698
Oral or intravenous methylprednisolone for acute relapses of MS?
699
Oral or Intravenous N-Acetylcysteine for Acetaminophen Poisoning?
700
Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia
701
Oral or parenteral therapy for B12 deficiency
702
Oral or parenteral therapy for vitamin B12 deficiency
703
Oral or parenteral therapy for vitamin B12 deficiency
704
Oral or parenteral therapy for vitamin B12 deficiency
705
Oral or rectal diclofenac for laparoscopic sterilization
706
Oral or topical administration of L-arginine changes the expression of TGF and iNOS and results in early wounds healing
707
Oral ornithine a-ketoglutarate accelerates healing of thesmall intestine and reduces bacterial translocation after abdominal radiation
708
Oral Oxycodone Compared With Intravenous Morphine Sulfate for Pain Management of Isolated Limb Trauma; a Randomized Clinical Trial
709
Oral Papillomatosis in a Dog: Surgical Management and Histopathological Findings
710
Oral Paraneoplastic Pemphigus and Pharyngeal Squamous Cell Carcinoma: A Rare Case Report and Review of Literature
711
Oral pathology – Pertinent papers published in 2002–2003: A personal view
712
Oral pathology – Pertinent papers published in 2004: A personal view
713
Oral pemphigoid autoantibodies preferentially target BP180 ectodomain
714
Oral peptide drug delivery: polymer–inhibitor conjugates protecting insulin from enzymatic degradation in vitro
715
ORAL PERFORMANCE AS SIREN The Example of Ozoemena Nwa Nsugbe
716
Oral pH and drinking habit during ingestion of a carbonated drink in a group of adolescents with dental erosion
717
Oral phenylalanine loading test for the diagnosis of dominant guanosine triphosphate cyclohydrolase 1 deficiency
718
Oral physostigmine in alzheimerʹs disease: Effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma
719
Oral pigmented lesions
720
Oral Piracetam vs Betahistine in Outpatient Management of Peripheral Vertigo; a Randomized Clinical Trial
721
Oral pleasure and expatriate satisfaction: an empirical approach
722
Oral poliomyelitis vaccines
723
Oral Potentially Malignant Disorders: An Overview of More than 20 Entities
724
Oral prednisolone for viral wheeze in young children
725
Oral prednisolone for viral wheeze in young children
726
Oral prednisolone in the treatment of cervical radiculopathy: A randomized placebo controlled trial
727
Oral premalignancies and squamous cell carcinoma
728
Oral Premedication for Pediatric Cardiac Surgery: A Comparison of Midazolam, Ketamine and Midazolam plus Ketamine
729
Oral premedication in patients with a history suggesting hypersensitivity to iodinated contrast media
730
Oral Presentation Versus Role Playing in Medical Education: A Quasi-Experimental Study
731
Oral Presentation vs. Free Discussion: Iranian Intermediate EFL Learners’ Speaking Proficiency and Perception
732
Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD− S. Typhi-specific IgA and IgG B memory cells in humans
733
ORAL PROBIOTIK: PENDEKATAN BARU TERAPI HALITOSIS (Tinjauan Pustaka)
734
Oral Problems and Psychological Status of Older Adults Referred to Hospital and Its Relationship With Cognition Status, Stress, Anxiety, and Depression
735
Oral processing characteristics of solid meal components, and relations with food composition, sensory attributes & expected-satiation
736
Oral processing characteristics of solid savoury meal components, and relationship with food composition, sensory attributes and expected satiation
737
Oral processing, texture and mouthfeel: From rheology to tribology and beyond
738
Oral Propranolol for Treatment of Pediatric Capillary Hemangiomas
739
Oral propranolol premedication and hypotensive anesthesia in shoulder arthroscopic surgery: a randomized controlled double-blind study
740
Oral propranolol versus cryotherapy in the management of cutaneous hemangioma in infants and children
741
Oral Psyllium Herbal Laxative , Clinical Trial in a Difficult Group
742
Oral Pulse Granuloma- A Rare Entity
743
Oral Pushed Output: the Route to Longterm Grammatical Accuracy
744
Oral pyogenic granuloma: a review of 38 cases from Ibadan, Nigeria
745
Oral Quercetin Supplementation Enhances Adiponectin Receptor Transcript Expression in Polycystic Ovary Syndrome Patients: A Randomized Placebo-Controlled Double-Blind Clinical Trial
746
Oral Question Approach In Teaching By Malay Language Teachers: Observation Methode
747
Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis: The Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study Original Research Article
748
Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: The Oral Rapamune to Inhibit Restenosis (ORBIT) study Original Research Article
749
Oral rapamycin to prevent human coronary stent restenosis: A pilot study
750
Oral recombinant bovine somatotropin improves growth performance in rainbow trout (Oncorhynchus mykiss)
751
Oral Recombinant Mycobacterium bovis Bacillus Calmette–Guérin Expressing HIV-1 Antigens as a Freeze-Dried Vaccine Induces Long-Term, HIV-Specific Mucosal and Systemic Immunity
752
Oral Reconstruction of Hemi-Mandibulectomy Patients by Implant Overdenture: Report of Two Cases
753
Oral reconstruction using the peroneal flap
754
Oral Reference Dose for ethylene glycol based on oxalate crystal-induced renal tubule degeneration as the critical effect
755
Oral rehabilitation after radiotherapy; a review on prosthetic treatment options
756
Oral Rehabilitation and Management for Secondary Sjögren’s Syndrome in a Child
757
Oral rehabilitation by semi‑adjustable articulator
758
Oral Rehabilitation in Irradiated Patients: Implant- or Tooth-Supported Fixed Prosthesis? A Clinical Report
759
Oral Rehabilitation of a Patient with Papillon Lefèvre Syndrome Using Fixed Full-Arch Hybrid Prostheses Supported by Four Axially Loaded Implants: A Case Report with Four-Year Follow-up
760
Oral rehabilitation of amelogenesis imperfecta by complete overdentures: Case Report
761
Oral Rehabilitation of an Osteopetrosis Patient with Osteomyelitis
762
Oral Rehabilitation Using the Lip Muscle Trainer: A Narrative Review
763
Oral rehydration and hyponatraemia
764
Oral rehydration solution as adjuvant for oral vaccination
765
Oral rehydration solutions
766
Oral rehydration solutions for diabetics with acute diarrhoea
767
Oral rehydration therapy
768
Oral rehydration therapy improved for cholera
769
Oral renin inhibitors
770
Oral Requests in Advanced Level English Coursebooks and English Movies: An Evaluative Study
771
Oral resiquimod in chronic HCV infection: Safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies
772
Oral retinoids pose no threat to back bones
773
Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: A systematic review of the evidence from comparative trials Review Article
774
Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: A new potential treatment of osteoarthritis
775
Oral Schwannoma: A Systematic Review of the Case Reports
776
Oral Schwannoma: A Systematic Review of the Case Reports
777
Oral sealing using glue: a new method to distinguish between intestinal and dermal uptake of metals in earthworms
778
Oral sealing using glue: a new method to distinguish between intestinal and dermal uptake of metals in earthworms
779
Oral Selenium: Can It Prevent Contrast-Induced Nephropathy Following Coronary Angiography and Angioplasty
780
Oral self emulsifying powder of lercanidipine hydrochloride: Formulation and evaluation
781
Oral Self-Injurious Behaviors in Patients with Developmental Disabilities
782
Oral sensation of ethanol in a primate model III: responses in the lingual branch of the trigeminal nerve of Macaca mulatta
783
Oral sensations associated with the flavan-3-ols (+)catechin and (-)-epicatechin
784
Oral sensorimotor function for feeding in patients with tetanus
785
Oral sensory and cephalic hormonal responses to fat and non-fat liquids in bulimia nervosa
786
Oral Sildenafil After Bidirectional Cavopulmonary Shunt
787
Oral Sildenafil Ameliorates Impaired Pulmonary Circulation Early After Bidirectional Cavopulmonary Shunt
788
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
789
Oral sildenafil in erectile dysfunction
790
Oral sildenafil may reverse secondary ejaculatory dysfunction during infertility treatment
791
Oral Sildenafil Reduces Pulmonary Hypertension After Cardiac Surgery
792
Oral sildenafil therapy improves health-related quality of life and functional status in pulmonary arterial hypertension
793
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
794
Oral single pulse exposure of flounder Platichthys flesus to 4-tert-octylphenol: Relations between tissue levels and estrogenic effects
795
Oral single-dose pharmacokinetics of thiamphenicol in the sea-bass (Dicentrarchus labrax)
796
Oral single-dose pharmacokinetics of thiamphenicol in the sea-bass (Dicentrarchus labrax)
797
Oral Smokeless Tobacco Use with Special Reference to India
798
ORAL SNUFF AND CARCINOMA OESOPHAGUS
799
Oral Sodium Thiosulfate Solution as a Secondary Preventive Treatment for Calciphylaxis in Dialysis Patients
800
Oral solitary fibrous tumor: a cytogenetic analysis of tumor cells in culture with literature review
801
Oral species of Fusobacterium from human and environmental samples
802
Oral splint for temporomandibular joint disorders with revolutionary fluid system
803
Oral squamous cell cancer protein-protein interaction network interpretation in comparison to esophageal adenocarcinoma
804
Oral Squamous Cell Carcinoma and the Cutting Edge of Nanotechnology
805
Oral squamous cell carcinoma cells modulate osteoclast function by RANKL-dependent and -independent mechanisms
806
Oral Squamous Cell Carcinoma with an Unusual Clinical Manifestation: A Case Report
807
ORAL SQUAMOUS CELL CARCINOMA WITH PSEUDO-GLANDULAR DIFFERENTIATION
808
Oral Squamous Cell Carcinoma: Focus on Biomarkers for Screening
809
Oral squamous cell carcinoma: Like owner, like cat
810
Oral statins and increased bone-mineral density in postmenopausal women Original Research Article
811
Oral status and nutrition in the institutionalized elderly
812
Oral Stereognosis in Children With Cleft Palate and Normal Children
813
Oral steroids as a cause of diverticulum perforation
814
Oral sterol intake in The Netherlands: evaluation of the results obtained by GC analysis of duplicate 24-h diet samples collected in 1994
815
Oral Story as Source for Tourism: A Comparative between Malaysia and Singapore
816
Oral Storytelling as an Act of Resistance in Morrison’s Tar Baby
817
Oral Sub Mucous Fibrosis: Exploring Therapeutic Strategies Using -anti TGF β Drugs
818
Oral subchronic and genotoxicity studies conducted with the amino acid, l-glutamine
819
Oral submucous fibrosis and copper
820
Oral Submucous Fibrosis in a 15-year-old Boy: The First Case Report in Iran
821
Oral Submucous Fibrosis: a case report
822
Oral Submucous Fibrosis: A Chronic Deliberating Disease of Oral Cavity
823
Oral Substitution of Melatonin in Critical Care: A Pharmacokinetic Study in Patients with Intracranial Hemorrhage
824
Oral substitution treatments for opioid dependence
825
Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway
826
Oral Supplementation of B-Carotene Significantly Ameliorates Testicular Oxidative Stress in the Streptozotocin-Diabetic Rat
827
Oral Supplementation of β-Carotene Significantly Ameliorates Testicular Oxidative Stress in the Streptozotocin-Diabetic Rat
828
Oral supplements as adjunctive treatment to nutritionalcounseling in malnourished HIV infected patients: randomized controlled trial
829
Oral supplements differing in fat and carbohydrate content: effect on the appetite and food intake of undernourished elderly patients
830
Oral Surgery for Patients on Anticoagulant Therapy: Current Thoughts on Patient Management
831
ORAL SUSTAINED RELEASE PELLETS OF DILTIAZEM HCL WITH KOLLICOAT SR30
832
Oral Syphilis: A Reemerging Infection Prompting Clinicians’ Alertness
833
Oral Taurine Supplementation Modulates Ethanol-Conditioned Stimulus Preference
834
Oral Teratogenicity Studies of Methyl Bromide in Rats and Rabbits
835
Oral terbutaline after parenteral tocolysis: A randomized, double-blind, placebo-controlled trial
836
Oral terbutaline in the outpatient management of preterm labor
837
Oral testosterone supplementation and chronic low-grade inflammation in elderly men: A 26-week randomized, placebo-controlled trial
838
Oral Theophylline Changes Renal Carnitine Palmitoyltransferase Activity in Rats
839
Oral therapeutics and oral cosmetics
840
Oral Therapy in a Diabetic Patient With History of Infantile Hyperinsulinism
841
Oral Thioctic Acid (a-Lipoic Acid) and Gabapentin as Co-adjuvants in Paraneoplastic Neuropathic Pain
842
Oral tolerance and autoimmune diabetes—will hope triumph over experience?
843
Oral tolerance and OVA-induced tolerogenic dendritic cells reduce the severity of collagen/ovalbumin-induced arthritis in mice
844
Oral tolerance correlates with high levels of lymphocyte activity
845
Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis-inducedand high-fat-diet-driven atherosclerotic lesions
846
Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells
847
Oral tolerance: Mechanisms and possible role in inflammatory joint diseases
848
Oral Tolerance: New Approaches, New Problems
849
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial
850
Oral toxic exposure of titanium dioxide nanoparticles on serum biochemical changes in adult male Wistar rats
851
Oral toxic exposure of titanium dioxide nanoparticles on serum biochemical changes in adult male Wistar rats
852
Oral Toxicity and Carcinogenicity Studies of Sucrose Acetate Isobutyrate (SAIB) in the Fischer 344 Rat and B6C3F1 Mouse
853
ORAL TOXICITY AND REPELLENT EFFECT OF SOME INSECTICIDES AGAINST HONEYBEE WORKERS
854
Oral toxicity evaluation of kefir-isolated Lactobacillus kefiranofaciens M1 in Sprague–Dawley rats
855
Oral toxicity of a tocotrienol preparation in rats
856
Oral Toxicity of Bis(2-Ethylhexyl) Phthalate During Pregnancy and Suckling in the Long–Evans Rat
857
Oral Toxicity of Thymol, α-Pinene, Diallyl Disulfide and Trans-Anethole, and Their Binary Mixtures against Tribolium castaneum Herbst Larvae (Coleoptera: Tenebrionidae)
858
Oral toxicological studies of black soybean (Glycine max) hull extract: Acute studies in rats and mice, and chronic studies in mice
859
Oral Tradition and Identity of West Kalimantan Society
860
Oral tranexamic acid in treatment of melasma in Pakistani population: a pilot study
861
Oral transmission of BSE to primates
862
Oral transmucosal drug delivery for pediatric use
863
Oral treatment of transmissible gastroenteritis with natural human interferon alpha: A field study
864
Oral treatment of transmissible gastroenteritis with natural human interferon alpha: A field study
865
Oral treatment options for degenerative joint disease—presence and future
866
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials
867
Oral trovafloxacin compared with intravenous cefoxitin in the prevention of bacterial infection after elective vaginal or abdominal hysterectomy for nonmalignant disease
868
Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity
869
Oral ulcerations due to drug medications
870
Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study
871
Oral vaccination of African catfish with Vibrio anguillarum O2: effect on antigen uptake and immune response by absorption enhancers in lag time coated pellets
872
Oral vaccination of BacFish-vp6 against grass carp reovirus evoking antibody response in grass carp
873
Oral vaccination of dogs with recombinant rabies virus vaccines
874
Oral vaccination of fish againstVibrio anguillarumusing alginate microparticles
875
Oral vaccination of juvenile carp (Cyprinus carpio) and gilthead seabream (Sparus aurata) with bioencapsulatedVibrio anguillarumbacterin
876
Oral vaccines against cholera: lessons from Vietnam and elsewhere
877
Oral Verruciform Xanthoma within Lichen Planus: A Case Report and Literature Review
878
Oral Verrucous Carcinoma and Ameloblastoma: A Rare Coincidence
879
Oral Versus Intramuscular Ondansetron for Reducing Vomiting in Children with Acute Gastroenteritis: A Single-Blind Randomized Clinical Trial
880
Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study
881
Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice
882
Oral versus intravenous acetaminophen as a constituent of multimodal analgesia after coronary artery bypass graft surgery: A randomized, blinded trial
883
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis
884
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis
885
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis
886
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis
887
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis
888
Oral Versus Intravenous Rehydration of Moderately Dehydrated Children: A Randomized, Controlled Trial
889
ORAL VERSUS NASAL VASOPRESSIN IN THE TREATMENT OF NOCTURNAL ENURESIS IN 5- TO 12-YEAR-OLD CHILDREN
890
Oral versus Parenteral Iron Therapy for correction of Iron Deficiency Anaemia in Pregnancy
891
Oral versus rectal route of misoprostol administration: a randomized controlled trial
892
Oral versus vaginal misoprostol for induction of labor: A double-blind randomized controlled trial
893
Oral Versus Vaginal Misoprostol for Induction of Labour
894
Oral vinorelbine in metastatic breast cancer: A review of current clinical trial results
895
Oral viral infections
896
Oral vitamin b12 therapy in vitamin b12 deficiency
897
Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation
898
Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect
899
Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial
900
Oral vitamin K prophylaxis for newborn infants: safe enough?
901
Oral Vocabulary as a Predictor of English Language Proficiency among Malaysian Chinese Preschool Children
902
Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: A prospective randomized clinical trial: Mombelli G, Pezzoli R, Pinoja-Lutz G, et al Arch Intern Med 159:53–58 January
903
Oral Wheat Immunotherapy in a Patient with Anaphylaxis Despite Negative Sensitization Tests
904
Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial
905
Oral Yeast Colonization and Fungal Infections in Peritoneal Dialysis Patients: A Pilot Study
906
Oral Zinc Sulfate as Adjuvant Treatment in Children With Nephrolithiasis: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
907
Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: A double blind, randomized controlled clinical trial
908
ORAL ZINC SULPHATE VS. TOPICAL APPLICATION OF SALICYLIC (16.7%) LACTIC ACID (16.7%) COMBINATION IN THE TREATMENT OF PLANTAR WARTS
909
Oral Zinc Supplementation in Chronically HEV-Infected Patients Not Responding to Ribavirin Monotherapy
910
Oral Zinc Supplementation Positively Affects Linear Growth, But not Weight, in Children 6‑24 Months of Age
911
Oral, gastric and intestinal influences on the control of appetite and feeding in humans
912
Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer – Review of the literature
913
OralCard: A bioinformatic tool for the study of oral proteome
914
Oral-contraceptive use and risk of hip fracture: a case-control study
915
ORAL-DENTAL HEALTH PROTOCOLS IN PEDIATRIC INTENSIVE CARE UNITS
916
Oral-facial-digital syndrome type II: Transitional type between Mohr and Varadi
917
Oral-facial-digital syndrome type VI with self mutilations
918
Oral-facial-digital syndrome with mesoaxial polysyndactyly,common AV canal,hirschsprung disease and sacral dysgenesis: Probably a transitional type between II,VI,variant of type VI or a new type
919
Oral-health status of inpatients with schizophrenia in Taiwan
920
Orality and literacy in public discourse: An interview of Hannah Arendt
921
Orality and the Sermonic Tradition in J. California Cooperʹʹs Some People, Some Other Place- A Study of the Narrative Voice
922
Orality in the library: How mobile phones challenge our understandings of collaboration in hybridized information centers Original Research Article
923
Orality to literacy: effects on nursing knowledge
924
Orality, Storytelling the Metafictional Space of Narration in Stephen Crane’s The Red Badge of Courage
925
Orall -arginine improves endothelial dysfunction in patients with essential hypertension
926
Oral-Language Skills of the Iranian Pupils With Hearing-Impairment
927
Orally active 1,2,4-trioxepanes: Synthesis and antimalarial activity of a series of 7-arylvinyl-1,2,4-trioxepanes against multidrug-resistant Plasmodium yoelii in Swiss mice Original Research Article
928
Orally active 4-amino-5-diarylurea-furo[2,3-d]pyrimidine derivatives as anti-angiogenic agent inhibiting VEGFR2 and Tie-2
929
Orally active amino functionalized antimalarial 1,2,4-trioxanes
930
Orally active antimalarials: Synthesis and bioevaluation of a new series of steroid-based 1,2,4-trioxanes against multi-drug resistant malaria in mice
931
Orally active anti-proliferation agents: novel diphenylamine derivatives as FGF-R2 autophosphorylation inhibitors
932
Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety Original Research Article
933
Orally active cephalosporins. Part 2: Synthesis, structure–activity relationships and oral absorption of cephalosporins having a C-3 pyridyl side chain Original Research Article
934
Orally active cephalosporins. Part 3: synthesis, structure–activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporins Original Research Article
935
Orally Active Cephalosporins. Part 4: Synthesis, Structure–Activity Relationships and Oral Absorption of Novel 3-(4-Pyrazolylmethylthio)cephalosporins with Various C-7 Side Chains Original Research Article
936
Orally active cephalosporins: synthesis, structure–activity relationships and oral absorption of 3-[(E) and (Z)-2-Substituted vinyl]-cephalosporins Original Research Article
937
Orally active docetaxel analogue: synthesis of 10-deoxy-10-C-morpholinoethyl docetaxel analogues
938
Orally active esters of dihydroartemisinin: Synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice
939
Orally active factor Xa inhibitor: synthesis and biological activity of masked amidines as prodrugs of novel 1,4-diazepane derivatives Original Research Article
940
Orally active factor Xa inhibitors: 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine derivatives
941
Orally active factor Xa inhibitors: Investigation of a novel series of 3-amidinophenylsulfonamide derivatives using an amidoxime prodrug strategy
942
Orally active indole N-oxide PDE4 inhibitors
943
Orally active inhibitors of stromelysin-1 (MMP-3)
944
Orally active insulin mimics: where do we stand now?
945
Orally active iron chelators
946
Orally active PDE4 inhibitors with therapeutic potential
947
Orally active prostacyclin analogue in primary pulmonary hypertension
948
Orally active thrombin inhibitors. Part 1: Optimization of the P1-moiety
949
Orally active thrombin inhibitors. Part 2: Optimization of the P2-moiety
950
Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice
951
Orally administered heparin for preventing deep venous thrombosis
952
Orally administered LPS enhances head kidney macrophage activation with down-regulation of IL-6 in common carp (Cyprinus carpio)
953
Orally Administration of Propranolol, Lorazepam, and Combination of Propranolol/Lorazepam, and Reducing Anxiety Before Surgery
954
Orally Administration of Propranolol, Lorazepam, and Combination of Propranolol/Lorazepam, and Reducing Anxiety Before Surgery
955
Orally and transdermally replaced estradiol improves endothelial function equally in middle-aged women after surgical menopause
956
Orally available cidofovir derivative active against smallpox
957
Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus
958
Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics
959
Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model
960
Orally bioavailable prodrugs of a BCS class 2 molecule, an inhibitor of HIV-1 reverse transcriptase
961
Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K
962
Orally bioavailable, indole-based nonpeptide GnRH receptor antagonists with high potency and functional activity
963
Orally disintegrating tablets prepared by a co-processed mixture of micronized crospovidone and mannitol using a ball mill to improve compactibility and tablet stability
964
Orally Disintegrating Tablets: A Review
965
Orally Efficacious NR2B-Selective NMDA Receptor Antagonists
966
Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif
967
Orally provoked urinary nickel excretion during disulfiram treatment
968
Oralmucoadhesive paste of Triamcinolone Acetonide and Zinc Sulfate: Preparation and in vitro physicochemical characterization
969
Oral-Periodontal Health and Cytokine Storm: Correlation and Preventive Measures
970
Oral-to-inhalation route extrapolation in occupational health risk assessment: a critical assessment
971
Orang Asli (aboriginal) community participation in the tourism industry - A preliminary survey of Belum-Temenggor
972
Orang Asli Talks in Akiya’s Tuntut
973
Orang Kulisusu. Identitas dan Kekuasaan Reproduksi Identitas Kultural dalam Proses Pemekaran Kabupaten Buton Utara
974
Orang Pekak Sebagai Cacat Atau Pengguna Minoriti Bahasa: Perspektif Perubatan Dan Linguistik
975
Orang Suku Laut dan Orang Melayu di Kepulauan Riau: Sebuah Tafsir Deskriptif-Etnografis
976
Orange (Citrus sinensis) juice concentration by reverse osmosis Original Research Article
977
Orange and green monkeys jumping around the room
978
Orange and red organic light-emitting devices using aluminum tris(5-hydroxyquinoxaline)
979
Orange and Sunlight: A Recipe for Blisters
980
Orange emission enhancement by energy transfer in Sr3Al2O5Cl2:Ce3+, Eu2+ phosphor for solid-state lighting
981
Orange emissive phosphor for warm-white light-emitting diodes
982
Orange G and Remazol Brilliant Blue R decolorization by white rot fungi Dichomitus squalens, Ischnoderma resinosum and Pleurotus calyptratus
983
Orange Harvesting Systems Review Review Article
984
Orange Hot’ Anthurium
985
Orange II adsorption on palygorskites modified with alkyl trimethylammonium and dialkyl dimethylammonium bromide — An isothermal and kinetic study
986
Orange II photocatalysis on immobilised TiO2: Effect of the pH and H2O2
987
Orange is good for health of hunters
988
Orange juice concentration by osmotic evaporation and membrane distillation: A comparative study Original Research Article
989
Orange juice—anticancer activity
990
Orange juice—anticancer activity
991
Orange Luminescence and Structural Properties of Three Isostructural Halocyclohexylisonitrilegold(I) Complexes
992
Orange oil stability in spray dry delivery systems
993
Orange peel as an adsorbent in the removal of Acid violet 17 (acid dye) from aqueous solutions
994
Orange Peel Essential Oil as Component of a Metal Sensor for Lead (II) Ion Determination in Aqueous Solutions
995
Orange peel pretreatment in a novel lab-scale direct steam-injection apparatus for ethanol production
996
Orange pulp improves antioxidant status and suppresses lipid peroxidation in orchidectomized male rats
997
Orange tree simulation under heterogeneous environment using agent-based model ORASIM
998
Orange-spotted grouper (Epinephelus coioides) TLR2, MyD88 and IL-1β involved in anti-Cryptocaryon irritans response
999
Orange-spotted grouper (Epinephelus coioides) toll-like receptor 22: Molecular characterization, expression pattern and pertinent signaling pathways
1000
Orangutan population density, forest structure and fruit availability in hand-logged and unlogged peat swamp forests in West Kalimantan, Indonesia Original Research Article
بازگشت